Results 271 to 280 of about 39,021 (326)

Circulating tumour DNA in patients with stage III colon cancer: multicentre prospective PROVENC3 study. [PDF]

Br J Surg
Rubio-Alarcón C, Georgiadis A, Franken IA, Wang H, van Nassau SCMW, Schraa SJ, van der Kruijssen DEW, van Rooijen K, Linders TC, Delis-van Diemen P, Alkemade M, Bolijn A, Tijssen M, Lemmens M, Meiqari L, Ketelaars SLC, Closa-Mosquera A, van Dongen MMW, Lanfermeijer M, Lissenberg-Witte BI, Bosch LJW, Bisschop-Snetselaar T, Adriaans BC, Greer A, Riley D, White JR, Greco C, Cox L, Fox J, Victor K, Leech C, Angiuoli SV, Kok NFM, Punt CJA, van den Broek D, Koopman M, Meijer GA, Velculescu VE, Roodhart JML, Coupé VMH, Sausen M, Vink GR, Fijneman RJA, Other Members of the PLCRC-MEDOCC Group .   +43 more
europepmc   +1 more source

Pursuit of precision oncology in the treatment of metastatic hormone receptor–positive breast cancer: Making strides or barely moving?

CA: A Cancer Journal for Clinicians, Volume 76, Issue 1, January/February 2026.
Ilana Schlam, Ajay Dhakal
wiley   +1 more source

Real-world utilization of tissue-free circulating tumor DNA (ctDNA) monitoring in cancer patients receiving immune checkpoint inhibitors (ICI)

Sameek Roychowdhury, Júlia C.F. Quintanilha, Candice Francheska Tambaoan, Amaya Gascó, Merrida Childress   +4 more
openalex   +1 more source

Evaluation of Circulating Tumor DNA as a Biomarker for Chemoresistance in Colorectal Cancer.

J Pharm Bioallied Sci
Lakshmi KR, Sankaranarayanan CS, Gogineni RAS, Shaheen KA, Peddi P.   +4 more
europepmc   +1 more source

Liquid biopsy in cancer diagnosis and prognosis: a paradigm shift in precision oncology. [PDF]

Front Mol Biosci
Abreu RDS, Ferreira DDP, de Araujo NS, Horita S, Tilli TM, Degrave W, Moreira ADS, Waghabi MC.   +7 more
europepmc   +1 more source

Table S4 from ctDNA Longitudinal Analysis during Total Neoadjuvant Therapy and Nonoperative Management for Locally Advanced Rectal Cancer: A Biomarker Study from the NOMINATE Trial

Takashi Akiyoshi, Eiji Shinozaki, Yusuke Maeda, Senzo Taguchi, Akiko Chino, Yutaka Hanaoka, Shigeo Toda, Shuichiro Matoba, Antony Tin, Erik Spickard, Tetsuro Tominaga, Kohei Shigeta, Koji Okabayashi, Shimpei Matsui, Toshiki Mukai, Tomohiro Yamaguchi, Hiroki Osumi, Adham Jurdi, Minetta C. Liu, Naoki Miyazaki, Kensei Yamaguchi   +20 more
openalex   +1 more source

Ultrasensitive ctDNA monitoring for organ preservation in patients with locally advanced rectal cancer. [PDF]

NPJ Precis Oncol
Manca P, Chen CT, Shah F, Lee C, Domenico D, Omer D, Gonzalez S, De Bruijn I, Ahuno S, Chatila WK, Darmofal M, Tavassoly I, Widman AJ, Berger MF, Loomis B, Papaemmanuil E, Yaeger R, Zviran A, Garcia-Aguilar J, Sanchez-Vega F.   +19 more
europepmc   +1 more source

Supplementary Figure S7 from Integrating ctDNA Dynamics and Sequential Organoid Drug Screening Enhances Breast Cancer Treatment Efficacy

Jialin Liu, Fang Fang, Weiguang Yuan, Tao Chen, Ji Wang, Xiaping Miao, Yuhuan Meng, Chen Song, Wanchun Tan, Jing An, A Nanding, Dalin Li, Youxue Zhang, Yiran Jiang, Yanbo Chen, Shouping Xu, Guoqiang Zhang, Yanni Song, Hui Li, Yajie Gong, Yuanyuan Yu, Siwei Li, Xingda Zhang, Shilu Zhao, Wenhui Hao, Da Pang, Jun Tian, Shihui Yu, Xianyu Zhang   +28 more
openalex   +1 more source

Personalized Circulating Tumor DNA Assay to Assess Long-Term Clinical Benefit in Patients with Advanced Melanoma. [PDF]

Cancers (Basel)
Martínez-Vila C, Teixido C, Martín R, Aya F, Sudhaman S, Budde GL, González-Navarro EA, Alos L, Castrejon N, Ortiz JB, Krainock M, Liu MC, Arance A.   +12 more
europepmc   +1 more source

Supplementary Figure 5 from Measurement of ctDNA Tumor Fraction Identifies Informative Negative Liquid Biopsy Results and Informs Value of Tissue Confirmation

Christian Rolfo, Russell W. Madison, Lincoln W. Pasquina, Derek W. Brown, Yanmei Huang, Jason D. Hughes, Ryon P. Graf, Geoffrey R. Oxnard, Hatim Husain   +8 more
openalex   +1 more source